Cheng J, Gao J, Li J, Tian H
Apoptosis. 2025; .
PMID: 40042745
DOI: 10.1007/s10495-025-02098-w.
Lu T, Li W
Cancers (Basel). 2025; 17(3).
PMID: 39941753
PMC: 11816126.
DOI: 10.3390/cancers17030384.
Zhu X, Wu Y, Li Y, Zhou X, Watzlawik J, Chen Y
Nat Commun. 2024; 15(1):10163.
PMID: 39580479
PMC: 11585635.
DOI: 10.1038/s41467-024-54344-5.
Zhang X, Rao M, Xu G
Arch Med Sci. 2024; 20(2):494-505.
PMID: 38757021
PMC: 11094828.
DOI: 10.5114/aoms/152174.
Zheng H, Haroon K, Liu M, Hu X, Xu Q, Tang Y
Int J Mol Sci. 2024; 25(2).
PMID: 38255866
PMC: 10815250.
DOI: 10.3390/ijms25020792.
Maternal CXCR4 deletion results in placental defects and pregnancy loss mediated by immune dysregulation.
Lyu F, Burzynski C, Fang Y, Tal A, Chen A, Kisa J
JCI Insight. 2023; 8(21.
PMID: 37815869
PMC: 10721256.
DOI: 10.1172/jci.insight.172216.
The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways.
Bakhtiyari M, Liaghat M, Aziziyan F, Shapourian H, Yahyazadeh S, Alipour M
Cell Commun Signal. 2023; 21(1):252.
PMID: 37735675
PMC: 10512514.
DOI: 10.1186/s12964-023-01282-2.
Plasma cells are not restricted to the CD27+ phenotype: characterization of CD27-CD43+ antibody-secreting cells.
Covens K, Verbinnen B, de Jong B, Moens L, Wuyts G, Verheyen G
Front Immunol. 2023; 14:1165936.
PMID: 37492569
PMC: 10364057.
DOI: 10.3389/fimmu.2023.1165936.
Targeting CXCR4 and CD47 Receptors: An Overview of New and Old Molecules for a Biological Personalized Anticancer Therapy.
Leo M, Sabatino L
Int J Mol Sci. 2022; 23(20).
PMID: 36293358
PMC: 9604048.
DOI: 10.3390/ijms232012499.
Development and characterization of a CRISPR/Cas9-mediated knockout chicken model lacking mature B and T cells.
Lee K, Choi H, Park K, Woo S, Kim Y, Han J
Front Immunol. 2022; 13:892476.
PMID: 36032098
PMC: 9403712.
DOI: 10.3389/fimmu.2022.892476.
Expression of CD117 (c-Kit) on Circulating B Cells in Pediatric Schistosomiasis.
Onkanga I, Hamilton R, Mwinzi P, Schneider T, Ondigo B, Sang H
Infect Immun. 2022; 90(8):e0016022.
PMID: 35862720
PMC: 9387214.
DOI: 10.1128/iai.00160-22.
A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia.
Smith A, Eiken A, Skupa S, Moore D, Umeta L, Smith L
Int J Mol Sci. 2022; 23(12).
PMID: 35743155
PMC: 9224275.
DOI: 10.3390/ijms23126712.
IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity.
Das Gupta D, Paul C, Samel N, Bieringer M, Staudenraus D, Marini F
Cell Death Differ. 2022; 29(11):2163-2176.
PMID: 35459909
PMC: 9613660.
DOI: 10.1038/s41418-022-01005-z.
Chemokine C-X-C receptor 4 mediates recruitment of bone marrow-derived nonhematopoietic and immune cells to the pregnant uterus†.
Fang Y, Lyu F, Abuwala N, Tal A, Chen A, Taylor H
Biol Reprod. 2022; 106(6):1083-1097.
PMID: 35134114
PMC: 9198949.
DOI: 10.1093/biolre/ioac029.
Retention of the NLRP3 Inflammasome-Primed Neutrophils in the Bone Marrow Is Essential for Myocardial Infarction-Induced Granulopoiesis.
Sreejit G, Nooti S, Jaggers R, Athmanathan B, Park K, Al-Sharea A
Circulation. 2021; 145(1):31-44.
PMID: 34788059
PMC: 8716427.
DOI: 10.1161/CIRCULATIONAHA.121.056019.
Roles of Neutrophils in Glioma and Brain Metastases.
Lin Y, Wei K, Chen P, Lim M, Hwang T
Front Immunol. 2021; 12:701383.
PMID: 34484197
PMC: 8411705.
DOI: 10.3389/fimmu.2021.701383.
Niche-directed therapy in acute myeloid leukemia: optimization of stem cell competition for niche occupancy.
Patel S, Dalela D, Fan A, Lloyd M, Zhang T
Leuk Lymphoma. 2021; 63(1):10-18.
PMID: 34407733
PMC: 9023050.
DOI: 10.1080/10428194.2021.1966779.
Diversity of Rainbow Trout Blood B Cells Revealed by Single Cell RNA Sequencing.
Perdiguero P, Morel E, Tafalla C
Biology (Basel). 2021; 10(6).
PMID: 34207643
PMC: 8227096.
DOI: 10.3390/biology10060511.
Chess Not Checkers: Complexities Within the Myeloid Response to the Acute Kidney Injury Syndrome.
Nash W, Okusa M
Front Med (Lausanne). 2021; 8:676688.
PMID: 34124107
PMC: 8187556.
DOI: 10.3389/fmed.2021.676688.
Tumor necrosis: A synergistic consequence of metabolic stress and inflammation.
Yee P, Li W
Bioessays. 2021; 43(7):e2100029.
PMID: 33998010
PMC: 8217290.
DOI: 10.1002/bies.202100029.